Treatment will depend on your child’s symptoms, age, and general health. It will also depend on how severe the condition is. Nearly half of all children with JIA recover fully. Others may have ...
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive interim efficacy data from the Phase I stage of its ...
Global Food Yields Have Grown Steadily During Last Six Decades, Study Finds Nov. 27, 2024 — Contrary to widespread concerns that global crop yields have stagnated in recent decades, a ...
The US Food and Drug Administration (FDA) has approved ustekinumab -kfce (Yesintek) as a biosimilar to ustekinumab (Stelara) for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis, ...